Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
X
publication

Distinct genetic pathways define pre-leukemic and compensatory clonal hematopoiesis in Shwachman-Diamond syndrome


Kennedy, A. L. et al.
BioRxiv (2020)
Abstract

Shwachman-Diamond syndrome (SDS) is an inherited bone marrow failure syndrome with predisposition to developing leukemia. We found that multiple independent somatic hematopoietic clones arise early in life, most commonly harboring heterozygous mutations in EIF6 or TP53. EIF6 mutations cause functional compensation for the germline deficiency by alleviating the SDS ribosome joining defect, improving translation, and reducing p53 activation. TP53 mutations decrease checkpoint activation without affecting ribosome assembly. We link development of leukemia with acquisition of biallelic TP53 alterations. Our results define distinct pathways of clonal selection driven by germline fitness constraint and provide a mechanistic framework for clinical surveillance.



Authors

Kennedy, A. L., Myers, K. C., Bowman, J., Gibson, C. J., Camarda, N. D., Furutani, E. M., Muscato, G. M., Klein, R. H., Ballotti, K., Liu, S., Harris, C. E., Galvin, A., Malsch, M., Dale, D., Gansner, J. M., Nakano, T. A., Bertuch, A., Vlachos, A., Lipton, J. M., Castillo, P., Connelly, J., Churpek, J., Edwards, J. R., Hijiya, N., Ho, R. H., Hofmann, I., Huang, J. N., Keel, S., Lamble, A., Lau, B. W., Norkin, M., Stieglitz, E., Stock, W., Walkovich, K., Boettcher, S., Brendel, C., Fleming, M. D., Davies, S. M., Weller, E. A., Bahl, C., Carter, S. L., Shimamura, A., Lindsley, R. C.



VIEW

publication
Single-cell genomics reveals the genetic and molecular bases for escape from mutational epistasis in myeloid neoplasms.
Taylor, J.
Blood (2020)
publication
Biological and clinical significance of dysplastic hematopoiesis in patients with newly diagnosed multiple myeloma.
Maia, C.
Blood (2020)
publication
Molecular mechanisms mediating relapse following ivosidenib monotherapy in IDH1-mutant relapsed or refractory AML.
Choe, S.
Blood Advances (2020)
publication
Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML.
DiNardo, C.D.
Blood (2020)
REQUEST QUOTE